| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Novartis AG (NVS) has 0 insiders with recent SEC Form 4 filings, including 3 buys and 15 sells. NVS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2017 | Novartis Bioventures Ltd | 10% Owner | Sell | 46,261 | $23.93 | $1,107,072.52 | -1.0% | |
| May 26, 2017 | Novartis Bioventures Ltd | 10% Owner | Sell | 5,353 | $25.14 | $134,592.44 | -0.1% | |
| May 24, 2017 | Novartis Bioventures Ltd | 10% Owner | Sell | 17,451 | $25.01 | $436,364.00 | -0.7% | |
| May 18, 2017 | Novartis Bioventures Ltd | 10% Owner | Sell | 9,019 | $25.50 | $229,963.76 | -0.4% | |
| May 17, 2017 | Novartis Bioventures Ltd | 10% Owner | Sell | 42,615 | $25.90 | $1,103,625.63 | -0.9% | |
| Mar 15, 2017 | Novartis Bioventures Ltd | 10% Owner | Buy | 560,000 | $5.00 | $2,800,000.00 | +10.7% | |
| Mar 1, 2017 | Novartis Bioventures Ltd | 10% Owner | Sell | 84,615 | $20.96 | $1,773,163.85 | -0.6% | |
| Oct 31, 2016 | Novartis Bioventures Ltd | 10% Owner | Sell | 339 | $13.00 | $4,407.00 | -0.5% | |
| Oct 31, 2016 | Novartis Bioventures Ltd | 10% Owner | Buy | 84,615 | $13.00 | $1,099,995.00 | +3.4% | |
| May 11, 2016 | Novartis Institutes For Biomedical Research, Inc. | 10% Owner | Buy | 277,777 | $18.00 | $4,999,986.00 | +5.2% |